Pharmarise Holdings Income Statement

Financials in millions JPY. Fiscal year is June - May.

Millions JPY. Fiscal year is Jun - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 28, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021
Revenue	67,485	63,508	54,466	52,030	51,608	52,324
Revenue Growth (YoY)	11.78%	16.60%	4.68%	0.82%	-1.37%	2.54%
Cost of Revenue	58,152	54,542	46,017	43,896	43,491	44,256
Gross Profit	9,333	8,966	8,449	8,134	8,117	8,068
Selling, General & Admin	4,719	4,860	4,371	3,728	3,525	3,659
Amortization of Goodwill & Intangibles	763	763	557	635	700	738
Other Operating Expenses	3,048	3,048	2,605	2,332	2,371	2,417
Operating Expenses	8,503	8,671	7,533	6,695	6,596	6,821
Operating Income	830	295	916	1,439	1,521	1,247
Interest Expense	-251	-178	-66	-55	-65	-75
Interest & Investment Income	13	10	1	2	2	2
Other Non Operating Income (Expenses)	11	-10	-19	44	58	54
EBT Excluding Unusual Items	603	117	832	1,430	1,516	1,228
Gain (Loss) on Sale of Investments	-	7	19	30	-	-4
Gain (Loss) on Sale of Assets	19	20	-1	-4	2	61
Asset Writedown	-245	-258	-296	-393	-218	-51
Other Unusual Items	97	124	-411	-14	21	-32
Pretax Income	474	10	143	1,049	1,321	1,202
Income Tax Expense	589	390	485	702	864	782
Earnings From Continuing Operations	-115	-380	-342	347	457	420
Minority Interest in Earnings	7	13	-9	-14	-10	6
Net Income	-108	-367	-351	333	447	426
Net Income to Common	-108	-367	-351	333	447	426
Net Income Growth	-	-	-	-25.50%	4.93%	-26.17%
Shares Outstanding (Basic)	11	11	11	9	9	9
Shares Outstanding (Diluted)	11	11	11	12	12	12
Shares Change (YoY)	1.12%	7.58%	-15.61%	0.59%	0.20%	-1.03%
EPS (Basic)	-9.46	-32.42	-33.35	35.42	47.90	45.78
EPS (Diluted)	-9.46	-32.42	-33.35	26.86	36.22	34.59
EPS Growth	-	-	-	-25.83%	4.70%	-25.31%
Free Cash Flow	-	674	2,242	2,140	334	1,437
Free Cash Flow Per Share	-	59.53	213.04	171.61	26.94	116.15
Dividend Per Share	14.000	14.000	14.000	14.000	14.000	14.000
Gross Margin	13.83%	14.12%	15.51%	15.63%	15.73%	15.42%
Operating Margin	1.23%	0.46%	1.68%	2.77%	2.95%	2.38%
Profit Margin	-0.16%	-0.58%	-0.64%	0.64%	0.87%	0.81%
Free Cash Flow Margin	-	1.06%	4.12%	4.11%	0.65%	2.75%
EBITDA	2,565	1,788	2,086	2,663	2,829	2,591
EBITDA Margin	3.80%	2.81%	3.83%	5.12%	5.48%	4.95%
D&A For EBITDA	1,735	1,493	1,170	1,224	1,308	1,344
EBIT	830	295	916	1,439	1,521	1,247
EBIT Margin	1.23%	0.46%	1.68%	2.77%	2.95%	2.38%
Effective Tax Rate	124.26%	3900.00%	339.16%	66.92%	65.41%	65.06%

Updated Feb 28, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.